Evidence map›Paper›PMID 34073385›Full record

ArticleAnimals : an open access journal from MDPI2021

Efficacy of Two Commercial Ready-To-Use PCV2 and

Gonzalo López-Lorenzo, Alberto Prieto, Cynthia López-Novo, Pablo Díaz, Ceferino Manuel López, Patrocinio Morrondo, Gonzalo Fernández, José Manuel Díaz-Cao

Open access · goldAbstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Efficacy of a new ready-to-use PCV2 andVeterinarni medicina · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gonzalo López-LorenzoINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.ORCID 0000-0001-8047-0413
Alberto PrietoINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.
Cynthia López-NovoINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.ORCID 0000-0001-7865-095X
Pablo DíazINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.ORCID 0000-0003-2445-1095
Ceferino Manuel LópezINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.ORCID 0000-0002-9151-3180
Patrocinio MorrondoINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.
Gonzalo FernándezINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.
José Manuel Díaz-CaoINVESAGA Group, Department of Animal Pathology, Faculty of Veterinary Sciences, Universidade de Santiago de Compostela, Avd. Carballo Calero s/n, 27002 Lugo, Spain.
Universidade de Santiago de Compostela · ES

Funding

MSD Animal Health Spain MSD Animal Health Spain
6 · The paper itself

Abstract

Porcine Circovirus Type 2 (PCV2) and

Indexed as

field trialMycoplasma hyopneumoniaePCV2ready-to-usesow parityvaccination

Identifiers

PMID34073385
PMCPMC8229604
OpenAlexW3164814534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.